Chinese University of Hong Kong

BioCentury’s roundup of translational innovation features two trios of papers: one on genetic control of cancer and the other on MASLD markers

Plus: Vertex’s diabetes cell therapy leads to insulin independence; Agios heads to Phase III in sickle cell; and updates from Biomea, Shionogi, Sagimet and more

Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities

BioCentury’s roundup of translational news

Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies

DISEASE CATEGORY: Ophthalmic
INDICATION: Optic neuropathy A team from the Chinese University of Hong Kong showed a GHRH receptor agonist could protect retinal ganglion cells from optic